Login / Signup

Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation.

Stefan RadtkeMark R EnstromDnyanada PandeElizabeth R DukeErwing Fabian Cardozo OjedaRavishankar MadhuStaci OwenGreta KanestromMargaret Lee CuiAnai M PerezJoshua T SchifferHans-Peter Kiem
Published in: Blood (2023)
Hematopoietic stem cells (HSCs) are assumed to be rare, infrequently dividing, long-lived, and not involved in immediate recovery after transplantation. Here we performed unprecedented high-density clonal tracking in nonhuman primates and found long-term persisting HSC clones to actively contribute during early neutrophil recovery and be the main source of blood production as early as 50 days post-transplant. Most surprisingly, we observed a rapid decline in the number of unique HSC clones, while persisting HSCs expanded undergoing symmetric divisions to create identical siblings and formed clonal pools ex vivo as well as in vivo. In contrast to the currently assumed model of hematopoietic reconstitution, we provide evidence for contribution of HSCs in short-term recovery as well as symmetric expansion of individual clones into pools. These findings provide novel insights into HSC biology informing the design of HSC transplantation and gene therapy studies.
Keyphrases
  • high density
  • gene therapy
  • stem cells
  • cell therapy
  • bone marrow
  • magnetic resonance
  • mesenchymal stem cells
  • autism spectrum disorder